A carregar...
Emerging and Resistant Infections
The lungs are a major target for infection and a key battleground in the fight against the development of antimicrobial drug–resistant pathogens. Ventilator-associated pneumonia (VAP) is associated with mortality rates of 24–50%. The optimal duration of antibiotic therapy against VAP is unknown, but...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Thoracic Society
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4200571/ https://ncbi.nlm.nih.gov/pubmed/25148425 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1513/AnnalsATS.201402-069PL |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|